DCF — ST. JOSEPH MEDICAL CENTER
Enterprise Value: $-251.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-251.2M
Enterprise Value
$-88.0M
PV of Cash Flows
$-163.2M
PV of Terminal Value
$-262.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $410.0M | $-11.0M | -3.0% | $-28.4M | $-25.8M |
| Year 2 | $422.3M | $-7.1M | -2.0% | $-25.0M | $-20.7M |
| Year 3 | $434.9M | $-3.0M | -1.0% | $-21.4M | $-16.1M |
| Year 4 | $448.0M | $-0.8M | -0.0% | $-19.8M | $-13.5M |
| Year 5 | $461.4M | $0.3M | 0.0% | $-19.2M | $-11.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-251.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$398.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03185311749713127
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5